Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Mamoru Harada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9737-0360; OpenAlex author ID A5000210861. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 7

  1. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells. Last author DOI 10.1002/cnr2.2075↗
  2. Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.15836↗
  3. Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0193990↗
  4. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. Last author DOI 10.18632/oncotarget.17157↗
  5. The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells. Last author DOI 10.1371/journal.pone.0127386↗
  6. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. Last author DOI 10.18632/oncotarget.5881↗
  7. The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancer. Last author DOI 10.1158/1535-7163.mct-12-0954↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mohammad Mahbubul Hoque · 2 shared papers, 2022–2024 · strength 0.51
  2. Nanae Harashima · 4 shared papers, 2013–2017 · strength 0.28
  3. Yoshitsugu Tajima · 3 shared papers, 2013–2018 · strength 0.21
  4. Hiroyuki Monma · 2 shared papers, 2013–2018 · strength 0.13
  5. Keizo Takenaga · 1 shared paper, 2017 · strength 0.10
  6. Miho Akimoto · 1 shared paper, 2017 · strength 0.10
  7. Yoko Hari · 1 shared paper, 2015 · strength 0.07
  8. Min Zhang · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.